• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
Endogenex

Endogenex

Bringing New Energy to the Treatment of Type 2 Diabetes

  • ReCET
  • Patients
  • Clinical Providers
  • About Us
    • News
    • Contact
  • Clinical Studies

Patients

Looking for a new way to help control your Type 2 Diabetes? 

ReCETTM by Endogenex* is a new investigational procedure designed to help people living with Type 2 Diabetes (T2D) bring control to their blood sugar levels.

What is Type 2 Diabetes?

Type 2 Diabetes is a progressive disease in which the body has difficulty maintaining normal blood sugar levels. Over time, excess sugar in the blood damages blood vessels, kidneys, eyes and other tissues in the body.

Individuals with diabetes

spend 2.3x more

on their medical costs than those without diabetes3

Adults with diabetes use an

average of 5.9

different medications6

Over

30 million

people live with T2D in the United States2

T2D treatment options

Current treatments for T2D focus primarily on lifestyle adjustments (diet and exercise) and the use of medications including insulin. An adult diagnosed with diabetes in the US uses an average of 5.9 different medications.6 Managing these medications and their side effects can be challenging; the costs of these medications can be significant.

The ReCET Procedure is an investigational, non-surgical treatment that is designed to promote regeneration of signaling cells in the small intestine that helps the body manage blood sugar levels.

During the ReCET Procedure, a physician will use a small camera to help guide a special catheter from your mouth down to the first part of your small intestine. Once the catheter is in place, it distributes precise, controlled electrical pulses into the wall of that section of your small intestine. These electrical pulses are intended to disrupt the poorly functioning signaling cells and start your body’s process of replacing them with new cells to help better manage your blood sugar levels.

You are asleep during the ReCET Procedure and are able to go home the same day. Most patients are able to start their normal activities the day after the procedure is done.

Take control of your Type 2 Diabetes

Learn more about the ReCET Procedure and options to participate in ongoing clinical studies. 


Learn more

* Caution: Exclusively a clinical investigational device. Limited by federal (or United States or similar) law to investigational use. Not for sale in any geography.

Endogenex, Inc.
151 Cheshire Ln N #400
Plymouth, MN 55441
+1 763-251-6820
info@endogenex.com

  • Facebook
  • Twitter
  • LinkedIn
  • Vimeo

References

Terms of Use

Privacy Policy

Cookie Policy

Join our mailing list


EndogenexTM and ReCETTM are registered trademarks of Endogenex, Inc. in the United States and other countries.

Copyright © 2023 Endogenex, Inc. All rights reserved.